Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunice S Wang

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Hematology. American Society of Hematology. Education Program|February 20, 2015
Treating acute myeloid leukemia in older adultsEunice S Wang
Blood|February 5, 2026
Clonal cacophony of AML relapseEunice S Wang
Blood|September 19, 2024
Curing APL in Latin America: more than just ATRAEunice S Wang
Best Practice & Research. Clinical Haematology|June 18, 2019
Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemiaEunice S Wang
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Common fungal infections in patients with leukemiaEunice S Wang
Blood|March 17, 2023
MDM2 and BCL-2: to p53 or not to p53?Eunice S Wang
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Guideline recommendations for the prophylaxis of invasive aspergillosis in AMLEunice S Wang
Best Practice & Research. Clinical Haematology|November 30, 2019
Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?Eunice S Wang
Expert Review of Clinical Pharmacology|January 8, 2021
Novel therapies for AML: a round-up for cliniciansMahesh Swaminathan, Eunice S Wang
Expert Opinion on Investigational Drugs|April 15, 2016
Inhibitors of LSD1 as a potential therapy for acute myeloid leukemiaAmanda Przespolewski, Eunice S Wang
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Hematology. American Society of Hematology. Education Program|February 20, 2015
Treating acute myeloid leukemia in older adultsEunice S Wang
Blood|February 5, 2026
Clonal cacophony of AML relapseEunice S Wang
Blood|September 19, 2024
Curing APL in Latin America: more than just ATRAEunice S Wang
Best Practice & Research. Clinical Haematology|June 18, 2019
Incorporating FLT3 inhibitors in the frontline treatment of FLT3 mutant acute myeloid leukemiaEunice S Wang
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Common fungal infections in patients with leukemiaEunice S Wang
Blood|March 17, 2023
MDM2 and BCL-2: to p53 or not to p53?Eunice S Wang
Clinical Advances in Hematology & Oncology : H&O|December 9, 2016
Guideline recommendations for the prophylaxis of invasive aspergillosis in AMLEunice S Wang
Best Practice & Research. Clinical Haematology|November 30, 2019
Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?Eunice S Wang
Expert Review of Clinical Pharmacology|January 8, 2021
Novel therapies for AML: a round-up for cliniciansMahesh Swaminathan, Eunice S Wang
Expert Opinion on Investigational Drugs|April 15, 2016
Inhibitors of LSD1 as a potential therapy for acute myeloid leukemiaAmanda Przespolewski, Eunice S Wang
Pageof 23